CD248/Endosialin: A Novel Pericyte Target in Renal Fibrosis.
作者信息
Chang-Panesso Monica, Humphreys Benjamin D
出版信息
Nephron. 2015;131(4):262-4. doi: 10.1159/000440890. Epub 2015 Dec 11.
Abstract
摘要
相似文献
1
CD248/Endosialin: A Novel Pericyte Target in Renal Fibrosis.
Nephron. 2015;131(4):262-4. doi: 10.1159/000440890. Epub 2015 Dec 11.
2
Genetic Deletion of the Stromal Cell Marker CD248 (Endosialin) Protects against the Development of Renal Fibrosis.
Nephron. 2015;131(4):265-77. doi: 10.1159/000438754. Epub 2015 Dec 4.
3
Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.
Microvasc Res. 2008 Nov;76(3):180-8. doi: 10.1016/j.mvr.2008.07.008. Epub 2008 Aug 8.
4
Endosialin-Expressing Pericytes Promote Metastatic Dissemination.
Cancer Res. 2016 Sep 15;76(18):5313-25. doi: 10.1158/0008-5472.CAN-16-0932.
5
CD248: A therapeutic target in cancer and fibrotic diseases.
Oncotarget. 2019 Jan 29;10(9):993-1009. doi: 10.18632/oncotarget.26590.
6
Mechanisms of fibrosis: the role of the pericyte.
Curr Opin Nephrol Hypertens. 2011 May;20(3):297-305. doi: 10.1097/MNH.0b013e328344c3d4.
7
CD248 expression on mesenchymal stromal cells is required for post-natal and infection-dependent thymus remodelling and regeneration.
FEBS Open Bio. 2012 Jul 20;2:187-90. doi: 10.1016/j.fob.2012.07.003. Print 2012.
8
Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
J Formos Med Assoc. 2012 Nov;111(11):589-98. doi: 10.1016/j.jfma.2012.09.008. Epub 2012 Oct 24.
9
Kidney pericytes: a novel therapeutic target in interstitial fibrosis.
Histol Histopathol. 2012 Dec;27(12):1503-14. doi: 10.14670/HH-27.1503.
10
Novel antibody probes for the characterization of endosialin/TEM-1.
Oncotarget. 2016 Oct 25;7(43):69420-69435. doi: 10.18632/oncotarget.11018.
引用本文的文献
1
Microvascularization of the Vocal Folds: Molecular Architecture, Functional Insights, and Personalized Research Perspectives.
J Pers Med. 2025 Jul 7;15(7):293. doi: 10.3390/jpm15070293.
2
C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation.
FEBS J. 2019 Sep;286(17):3299-3332. doi: 10.1111/febs.14985. Epub 2019 Jul 29.
3
Adventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing.
Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1055-1071. doi: 10.1161/ATVBAHA.119.312399.
4
CD248: A therapeutic target in cancer and fibrotic diseases.
Oncotarget. 2019 Jan 29;10(9):993-1009. doi: 10.18632/oncotarget.26590.
5
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy.
Arthritis Res Ther. 2018 Oct 3;20(1):223. doi: 10.1186/s13075-018-1719-4.
6
Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin.
EMBO Mol Med. 2017 Jun;9(6):741-749. doi: 10.15252/emmm.201607222.
本文引用的文献
1
Paracrine Wnt1 Drives Interstitial Fibrosis without Inflammation by Tubulointerstitial Cross-Talk.
J Am Soc Nephrol. 2016 Mar;27(3):781-90. doi: 10.1681/ASN.2014121188. Epub 2015 Jul 23.
2
Anti-Endosialin Antibody-Drug Conjugate: Potential in Sarcoma and Other Malignancies.
Mol Cancer Ther. 2015 Sep;14(9):2081-9. doi: 10.1158/1535-7163.MCT-15-0312. Epub 2015 Jul 16.
3
CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism.
Gut. 2016 Jul;65(7):1175-85. doi: 10.1136/gutjnl-2014-308325. Epub 2015 Jun 15.
4
Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis.
Cell Stem Cell. 2015 Jan 8;16(1):51-66. doi: 10.1016/j.stem.2014.11.004. Epub 2014 Nov 20.
5
A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors.
Clin Cancer Res. 2015 Mar 15;21(6):1281-8. doi: 10.1158/1078-0432.CCR-14-1829. Epub 2014 Nov 14.
6
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
N Engl J Med. 2014 May 29;370(22):2083-92. doi: 10.1056/NEJMoa1402582. Epub 2014 May 18.
7
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
N Engl J Med. 2014 May 29;370(22):2071-82. doi: 10.1056/NEJMoa1402584. Epub 2014 May 18.
8
PDGF and the progression of renal disease.
Nephrol Dial Transplant. 2014 Feb;29 Suppl 1:i45-i54. doi: 10.1093/ndt/gft273.
9
Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
J Pathol. 2013 Nov;231(3):273-89. doi: 10.1002/path.4253.
10
CD248+ stromal cells are associated with progressive chronic kidney disease.
Kidney Int. 2011 Jul;80(2):199-207. doi: 10.1038/ki.2011.103. Epub 2011 Apr 13.
Zotero 插件